Written and maintained by CASRAI Editorial Board
Published · Last updated
On this page
General trade and policy information for lab and clinic staff, not legal, customs or medical advice. Status checked 2026-11-01.
Short answer
Section 232 is the U.S. trade-law authority under which the Commerce Department investigates whether imports of an article threaten national security. On September 2, 2025 the Secretary of Commerce opened one such investigation into personal protective equipment, medical consumables and medical equipment, including devices. An investigation is not a tariff: duties exist only if the President acts on the Secretary’s report.
Definition and scope
Section 232 of the Trade Expansion Act of 1962, as amended (19 U.S.C. 1862), lets the Secretary of Commerce determine “the effects on the national security of imports” of an article. The Bureau of Industry and Security (BIS) runs the investigations. The BIS Section 232 page (checked 2026-11-01) says the Secretary’s report to the President is prepared within 270 days of initiation and that the President can adjust the imports of an article and its derivatives.
The medical investigation was announced in a Federal Register notice of September 26, 2025 (FR Doc. 2025-18729, BIS docket 250924-0160, regulations.gov ID BIS-2025-0258). That notice requested public comments, due by October 17, 2025, directed to the criteria in 15 CFR 705.4. It is a request for information. It sets no duty rate and lists no tariff codes.
How the investigation clock works
The statute sets a sequence of deadlines. Each step below is stated in 19 U.S.C. 1862 (checked 2026-11-01):
| Step | What the statute says |
|---|---|
| 1. Initiation | The Secretary starts the investigation and consults the Secretary of Defense on methodological and policy questions. For the medical case: September 2, 2025. |
| 2. Commerce report | No later than 270 days after initiation, the Secretary submits a report to the President. |
| 3. Presidential decision | Within 90 days after receiving the report, the President decides whether he concurs with its findings. |
| 4. Implementation | If the President decides to act, the action must be implemented no later than 15 days after that determination. |
Worked date. Counting 270 days from September 2, 2025 gives May 30, 2026 as the statutory report deadline. As of 2026-11-01 the BIS Section 232 page still lists this investigation under ongoing investigations, with its initiation date, and displays no report, findings or action for it. Because the later steps are triggered by the President receiving a report, the dates after step 2 cannot be computed from the page alone. Check the BIS page and the Federal Register for the current status before relying on any of this.
What the medical investigation covers
The notice defines three groups “for purposes of this investigation”. These are the notice’s own definitions, quoted or closely followed:
| Group | Notice definition | Examples named in the notice |
|---|---|---|
| Personal protective equipment (PPE) | PPE used in health care settings | Surgical masks, N95 respirators, gloves, gowns, and related medical parts and components |
| Medical consumables | Single-use or short-term-use items used for patient diagnosis, treatment and prevention of conditions | Syringes, needles, infusion (IV) pumps, forceps, scalpels; IV bags, catheters, tracheostomy tubes, anesthesia equipment, gauze and bandages, sutures, diagnostic and laboratory reagents |
| Medical equipment | Durable equipment, tools and machines used in healthcare to support patient care | Carriages and wheelchairs, crutches, hospital beds; devices such as pacemakers, insulin pumps, coronary stents, heart valves, hearing aids, blood glucose monitors |
The notice states that pharmaceuticals (prescription and over-the-counter drugs, biologics and specialty drugs) are not covered because they are examined in a separate Section 232 investigation. The lists use the phrase “include but are not limited to”, so the examples are illustrations rather than a closed list.
Where it matters for labs, clinics and supply decisions
Several items in the notice’s lists are products that labs and clinics buy routinely, such as gloves, syringes and needles, and diagnostic and laboratory reagents. Product pages on this site that describe such items include surgical masks, IV infusion pumps, hospital beds and wheelchairs. Being named in the notice means a category is within the scope of the inquiry; it does not mean any duty applies to it.
A practical way to read any news about this investigation is to ask three questions, each answerable from primary documents:
- Has the Secretary’s report been published or transmitted, and by whom (BIS page, Federal Register)?
- Has the President issued a proclamation or other action under 19 U.S.C. 1862(c)?
- If so, does the action name the specific product classifications and effective dates, rather than only the categories in the 2025 notice?
Section 232 versus Section 301
Both authorities are cited in discussions of medical-supply costs, but they work differently. Section 232 begins with a Commerce Department investigation of the national-security effects of imports of an article; the President then decides on action. Section 301 duties on medical products come from a U.S. Trade Representative determination about products of China, with rates and dates set by product classification in the notice. For the 301 side, see Section 301 tariffs on medical products.
Common misunderstandings
“Section 232 is a tariff.”
It is an investigation authority. Duties or other import adjustments arise only if the President acts on a report.
“Everything medical is covered.”
The notice scopes three groups and excludes pharmaceuticals, which are handled in a separate investigation.
“The Federal Register notice contains the rates.”
It contains the scope, the definitions and the comment request. It states no rates.
FAQ
What is Section 232?
Section 232 of the Trade Expansion Act of 1962, as amended, is the provision under which Commerce assesses whether imports threaten national security and the President decides whether to adjust them.
When did the medical supplies investigation start?
The Secretary of Commerce initiated it on September 2, 2025, according to the Federal Register notice of September 26, 2025.
How long does Commerce have to report?
No later than 270 days after initiation under 19 U.S.C. 1862(b)(3)(A), which is May 30, 2026 for this investigation.
How long does the President have to decide?
Within 90 days after receiving the report, with implementation no later than 15 days after a decision to act.
Sources
- Bureau of Industry and Security, Commerce, “Notice of Request for Public Comments on Section 232 National Security Investigation of Imports of Personal Protective Equipment, Medical Consumables, and Medical Equipment, Including Devices,” 90 FR 46383, September 26, 2025 (https://www.govinfo.gov/content/pkg/FR-2025-09-26/html/2025-18729.htm), checked 2026-11-01.
- 19 U.S.C. 1862, Safeguarding national security (https://www.law.cornell.edu/uscode/text/19/1862), checked 2026-11-01.
- Bureau of Industry and Security, Section 232 Investigations (https://www.bis.gov/232), checked 2026-11-01.







